| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.046 | 0.6 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.16 | 0.6 |